Atezolizumab plus personalized neoantigen vaccination in urothelial cancer: a phase 1 trial
Mansi Saxena, Jonathan F. Anker, Julia Kodysh, Timothy J. O’Donnell, Anna Kamińska, Marcia Meseck, Olivia Hapanowicz, Scot A. Niglio, Andres M. Salazar, Hardik Shah, Yayoi Kinoshita, Rachel Brody, Alex Rubinsteyn, Robert Sebra, Nina Bhardwaj, Matthew D. Galsky
Topics & Concepts
AtezolizumabUrothelial cancerMedicineVaccinationCancer vaccineCancerOncologyImmunologyBladder cancerInternal medicineImmunotherapyPembrolizumabBladder and Urothelial Cancer TreatmentsCancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses